Results 131 to 140 of about 27,665 (215)

Treatment Patterns, Effectiveness, and Safety of Originator Insulin Glargine versus Insulin Glargine-yfgn within the Veterans Health Administration

Pharmacoepidemiology
We described insulin glargine (originator) and insulin glargine-yfgn (biosimilar) treatment patterns, assessed effectiveness and safety outcomes, and identified reasons for switching back to the originator product from the biosimilar.
Samantha Walczuk, Francesca E. Cunningham, Xinhua Zhao, Diane Dong, Peter A. Glassman, Donald R. Miller, Deborah Khachikian, Anthony Au, Cedric Salone, Kelly Bryan, Qoua Her, Sherrie L. Aspinall   +11 more
doaj   +1 more source

Medicine on demand, medication patterns and glycemic control in patients with type 2 diabetes [PDF]

, 2013
Diabetes mellitus is a metabolic disease that currently affects approximately 5% of the general population in Western countries. Type 2 diabetes mellitus accounts for 90-95% of all diabetes cases.
Lamberts, E.J.F., Pharmacoepidemiology, Sub Pharmacoepidemiology   +2 more
core  

Dermatological Disease at a Tertiary Military Hospital in Burundi: A Retrospective Review

International Journal of Dermatology, EarlyView.
Doriane Sabushimike, Alison K. Wright, Marc Nimburanira, Patrick Budengeri, Christopher E. M. Griffiths, Darren M. Ashcroft   +5 more
wiley   +1 more source

Risk of Heart Failure Hospitalization Associated With Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitors Versus Erythropoiesis‐Stimulating Agents: A Nationwide Claims‐Based Cohort Study

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 9, September 2026.
ABSTRACT Purpose Hypoxia‐inducible factor prolyl hydroxylase inhibitors (HIF‐PHIs) are increasingly used to treat renal anemia in patients with chronic kidney disease (CKD). We evaluated the risk of heart failure associated with HIF‐PHIs compared with erythropoiesis‐stimulating agents (ESAs) in routine clinical practice.
Yuki Kunitsu, Keiko Ikuta, Daiki Hira, Shunsaku Nakagawa, Tomohiro Terada   +4 more
wiley   +1 more source

Postpartum Psychotropic Treatment Patterns and Breastfeeding: Nationwide Clustering Study

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 9, September 2026.
ABSTRACT Introduction Postpartum psychotropic medication use is heterogeneous, comprising continuation of prenatal treatment, initiation, transient use and complex polypharmacy. Prior studies have reported the prevalence of potential infant exposure to psychotropics via breast milk, but characterisations better capturing the heterogeneity of this ...
Anders Hviid, Anna Laksafoss, Elisabeth O'Regan, Poul Videbech, Ingrid Bech Svalgaard   +4 more
wiley   +1 more source

Prescription Medication Use During Pregnancy and Postpartum in Sweden 2007 to 2022

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 9, September 2026.
ABSTRACT Purpose Medication use during pregnancy has increased worldwide. The aim was to investigate patterns of prescription medication use during pregnancy and postpartum in Sweden 2007–2022. Methods We conducted a population‐based drug utilization study with linked data from the Swedish Medical Birth and Prescribed Drug Registers.
Essi Whaites Heinonen, Awad I. Smew, Silvia Segovia Chacón, Ulrika Nörby, Olof Stephansson, Anne K. Örtqvist, Cathrine Axfors, Pär Karlsson, Carolyn E. Cesta   +8 more
wiley   +1 more source

Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry

Purpose: The first paper to specify the core content of pharmacoepidemiology as a profession was published by an ISPE (International Society for Pharmacoepidemiology) workgroup in 2012 (Jones JK et al. PDS 2012; 21[7]:677–689).
Cohet, Catherine, Pinheiro, Simone, Tilson, Hugh, Osborne, Vicki, Pont, Lisa, Chan, K. Arnold, Klungel, Olaf, Seeger, John, Edlavitch, Stanley, Bate, Andrew, Moeny, David, Winterstein, Almut G., PECP - Centre for Pharmacoepidemiology, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology, Brown, Joshua, Goodin, Amie, Layton, Deborah   +17 more
core  

Temporal Changes in Dispensing of Methylphenidate During Attention Deficit Hyperactivity Disorder Shortages in Australia: An Interrupted Time Series and Descriptive Analysis of National Dispensing Patterns

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 9, September 2026.
ABSTRACT Purpose To describe nationwide dispensing patterns of methylphenidate in Australia before and during recent prolonged supply shortages, and to assess the extent to which Section 19A (S19A) overseas substitutes contributed to population‐level utilisation during the shortage period.
George Gadalla, Wern Chai, Lisa Kalisch Ellett, Jack Janetzki   +3 more
wiley   +1 more source

Statistical Parametric Simulation Studies Based on Real Data

WIREs Computational Statistics, Volume 18, Issue 3, September 2026.
To generate more realistic parametric simulations, a common approach is to infer specific components of the data‐generating mechanisms considered in the simulation study from real datasets. This article reviews and formally discusses this process and argues for a more systematic approach to dataset selection.
Christina Sauer, F. Julian D. Lange, Maria Thurow, Ina Dormuth, Anne‐Laure Boulesteix   +4 more
wiley   +1 more source

Use of Attention Deficit Hyperactivity Disorder Medication Among Danish Children and Adolescents From 2010 to 2023

Acta Psychiatrica Scandinavica, Volume 154, Issue 3, Page 203-211, September 2026.
ABSTRACT Introduction Pharmacological treatment is an important component in the multimodal management of attention deficit hyperactivity disorder (ADHD), but contemporary trends in ADHD medication use among boys and girls in Denmark have not been fully characterized.
Maria Højgaard Stoltz‐Andersen, Martin Thomsen Ernst, Søren Dalsgaard, Lotte Rasmussen, Rikke Wesselhoeft   +4 more
wiley   +1 more source